Also trades as: 4568.T (JPX) · $vol 117M · DSNKY (OTC) · $vol 4M

$18.70

-0.40 (-2.09%)

Weekly Expected Move ±7.9%

$16 $17 $19 $20 $22

OTC · Healthcare · Drug Manufacturers - General · Tech Score Neutral · Power 52 · $34.0B mcap · 1.57B float · 0.0006% daily turnover · Short 78% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

Income Trends

Revenue

$2.14T +13.3% ▲

5Y CAGR: +17.3%

Gross Profit

$1.46T -0.5% ▼

5Y CAGR: +18.6%

Operating Income

$208.6B -37.1% ▼

5Y CAGR: +26.7%

Net Income

$261.5B -11.6% ▼

5Y CAGR: +28.1%

EPS (Diluted)

$140.61 -9.8% ▼

5Y CAGR: +29.2%

EBITDA

$286.6B -34.3% ▼

5Y CAGR: +16.4%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$1.04T	$1.28T	$1.60T	$1.89T	$2.14T
YoY Growth	+8.6%	+22.4%	+25.3%	+17.8%	+13.3%
Cost of Revenue	$362.8B	$363.5B	$415.3B	$415.8B	$673.3B
Gross Profit	$682.1B	$915.0B	$1.19T	$1.47T	$1.46T
Gross Margin	65.3%	71.6%	74.1%	78.0%	68.5%
R&D Expenses	$260.2B	$341.6B	$365.2B	$436.0B	$468.9B
SG&A Expenses	$339.4B	$451.6B	$637.0B	$731.2B	$785.6B
Operating Expenses	$599.6B	$793.1B	$974.8B	$1.14T	$1.25T
Operating Income	$73.0B	$120.6B	$211.6B	$331.9B	$208.6B
Operating Margin	7.0%	9.4%	13.2%	17.6%	9.8%
Interest Expense	$5.8B	$8.5B	$6.0B	$11.9B	$8.0B
Income Before Tax	$73.4B	$126.9B	$237.2B	$355.6B	$265.1B
Tax Expense	$6.5B	$17.7B	$36.2B	$59.9B	$3.6B
Net Income	$67.0B	$109.2B	$200.7B	$295.8B	$261.5B
Net Margin	6.4%	8.5%	12.5%	15.7%	12.2%
EPS (Diluted)	$34.91	$56.91	$104.62	$155.87	$140.61
EBITDA	$131.3B	$169.7B	$271.2B	$436.1B	$286.6B
Shares Outstanding	1.92B	1.92B	1.92B	1.90B	1.85B

Line Item	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3	FY2026 Q4
Revenue	$436.2B	$446.6B	$484.8B	$518.7B	$474.6B	$507.9B	$558.6B	$593.3B
Cost of Revenue	$95.0B	$98.0B	$128.4B	$94.3B	$92.3B	$158.2B	$118.4B	$304.3B
Gross Profit	$341.1B	$348.5B	$356.5B	$424.4B	$382.3B	$349.7B	$440.2B	$289.0B
Gross Margin	78.2%	78.0%	73.5%	81.8%	80.5%	68.9%	78.8%	48.7%
R&D Expenses	$100.7B	$92.6B	$109.3B	$133.3B	$106.0B	$113.3B	$122.2B	$127.0B
SG&A Expenses	$175.1B	$162.2B	$185.6B	$208.2B	$180.3B	$191.8B	$228.4B	$184.2B
Operating Expenses	$275.8B	$282.5B	$295.0B	$340.7B	$285.5B	$305.1B	$350.6B	$311.2B
Operating Income	$65.3B	$66.0B	$61.4B	$83.6B	$96.7B	$44.6B	$89.6B	-$22.2B
Operating Margin	15.0%	14.8%	12.7%	16.1%	20.4%	8.8%	16.0%	-3.7%
Interest Expense	$2.0B	$11.6B	$0	$4.2B	$10M	$846M	$2.2B	$3.6B
Income Before Tax	$110.1B	$82.4B	$82.4B	$80.6B	$105.4B	$58.6B	$106.8B	-$6.6B
Tax Expense	$24.8B	$21.1B	$20.5B	-$6.5B	$19.9B	$12.6B	$20.1B	-$49.3B
Net Income	$85.4B	$61.3B	$61.9B	$87.2B	$85.5B	$46.0B	$86.7B	$42.7B
Net Margin	19.6%	13.7%	12.8%	16.8%	18.0%	9.0%	15.5%	7.2%
EPS (Diluted)	$44.57	$32.18	$32.75	$46.39	$46.01	$24.83	$46.80	$23.97
EBITDA	$128.7B	$110.6B	$78.8B	$101.6B	$114.5B	$78.2B	$128.4B	-$981M
Shares Outstanding	1.92B	1.90B	1.89B	1.88B	1.86B	1.85B	1.85B	1.84B

DSKYF OTC

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet